Hims & Hers Health, Inc. Reports First Quarter 2026 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- 'Equal and opposite': BTIG's Krinsky sees sharp reversal ahead for chip stocks
Hims & Hers Health, Inc. (HIMS) Misses Q1 EPS by 41c, Misses on Revenue; Offers FY26 Revenue Guidance
May 11, 2026 4:06 PM EDTHims & Hers Health, Inc. (NYSE: HIMS) reported Q1 EPS of ($0.40), $0.41 worse than the analyst estimate of $0.01. Revenue for the quarter came in at $608 million versus the consensus estimate of $616.5 million.
GUIDANCE:
Hims & Hers Health, Inc. sees FY2026 revenue of $2.8-3... More
